Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
evonetix has raised $24.1M in total funding. The most recent round was Series B. The last funding was announced in February 2023.
evonetix's investors include Civilization Ventures, DCVC, Innovate UK, Morningside, Foresite Capital.
evonetix is headquartered in Little Chesterford, United Kingdom.
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
evonetix is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"evonetix — Funding & Investors." VCBacked, February 7, 2023, https://www.vcbacked.co/company/evonetix. Accessed July 19, 2026.
VCBacked. (2023). evonetix — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/evonetix
{{cite web |title=evonetix — Funding & Investors |url=https://www.vcbacked.co/company/evonetix |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated